Stem Cell Transplants for Early MS: Who Benefits Most?

Researchers are exploring HSCT as a rescue therapy in early-stage MS. But there's no consensus on best practices.

Related Keywords

London ,City Of ,United Kingdom ,Milan ,Lombardia ,Italy ,Antonio Scalfari ,Richard Nicholas ,Imperial College London ,Imperial College Healthcare ,University Of Bergen Norway ,Multiple Sclerosis Ms ,Multiple Sclerosis ,Us ,Transplantation Stem Cell ,Ransplantation Hematopoietic Stem Cell ,Hematopoietic Stem Cell Transplantation ,Stem Cell Transplantation ,Stem Cell Therapy ,Herapy Stem Cell ,Transplantation ,Transplant ,Monoclonal Antibody ,Etuximab ,Ituximab ,Relapsing Remitting Multiple Sclerosis ,Arms ,Ultiple Sclerosis Relapsing Remitting ,Clinical Researc ,